Bone Biologics Corp (NASDAQ:BBLG) currently has a daily average trading volume of 203.14K but it saw 63518 shares traded in last market. With a market cap of 2.32M USD, the company’s current market price of $0.94 came rising about 1.10 while comparing to the previous closing price of $0.93. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.25 and as low as $0.80.
Taking a look at 20-day trading activity of Bone Biologics Corp (BBLG) gives us an average price of $1.0670, while its current price level is -77.87% below from 52-week high level whereas it is 17.57% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.0373 while that of 200 days or SMA-200 reads an average of $1.4141. A closer look into the stock’s movement over the week reveals that its volatility is standing at 5.31% during that period while stretching the period over a month that increases to 9.04%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 39.69 which implies that the stock is in neutral territory.
Over the week, BBLG’s stock price is moving -11.26% down while it is -4.71% when we observe its performance for the past one month. Year-to-date it is 0.03% up and over the past year, the stock is showing a downside performance of -73.87%.
The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of -0.65 while estimate for next year EPS is -5.
Currently, Bone Biologics Corp’s total number of outstanding shares is 2.10M with 2.82% of that held by the insiders while 2.85% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -109.18% and return on equity (ROE) at -109.17%. Stock has a price to book (P/B) ratio of 0.52. Its return on asset (ROA) is -91.58% on average.
